During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed the data supporting the 2 newer BTK ...

6 - 24 hrs in CLL. 72 hrs after injection, TUCB content was lower than in not treated littermates. Conclusions: The differential entry and clearance across brain areas show regional difference in ...

Chronic lymphocytic leukemia (CLL) is usually a slow-growing blood cancer. Most people with CLL don’t notice any problems in the early stages of the disease. “In fact, we can do what we call ...

In chronic lymphocytic leukemia (CLL), the most prevalent lymphoid malignancy in western countries, patients have a median age at diagnosis of 72 years. In the last few years, there has been ...

Chronic lymphocytic leukemia-- or CLL-- is a type of cancer that happens in your blood and bone marrow, the spongy tissue inside your bones. While the exact cause isn't known, doctors do know that ...